4.8 Review

Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers

Journal

FRONTIERS IN IMMUNOLOGY
Volume 9, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2018.02480

Keywords

chemokine; chemokine receptor; melanoma; immune cell trafficking; cell migration

Categories

Funding

  1. Foundation ARC pour la recherche sur le cancer
  2. National Health and Medical Research Council (Australia) [APP1135898, 1054925]
  3. Victorian State Government Operational Infrastructure Support
  4. Australian Government NHMRC Independent Research Institute Infrastructure Support scheme
  5. Ligue contre le Cancer (equipe labelisee)
  6. Agence Nationale de la Recherche (ANR)-Projets blancs
  7. ANR under the frame of E-Rare-2
  8. ERA-Net for Research on Rare Diseases
  9. Association pour la recherche sur le cancer (ARC)
  10. Canceropole Ile-de-France
  11. Institut National du Cancer (INCa)
  12. Institut Universitaire de France
  13. Foundation pour la Recherche Medicale (FRM)
  14. European Commission (ArtForce)
  15. European Research Council (ERC)
  16. Foundation Carrefour
  17. Inserm (HTE)
  18. LeDucq Foundation
  19. LabEx Immuno-Oncology
  20. RHU Torino Lumiere
  21. SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE)
  22. SIRIC Cancer Research and Personalized Medicine (CARPEM)
  23. Paris Alliance of Cancer Research Institutes (PACRI)

Ask authors/readers for more resources

The tumor microenvironment is highly heterogeneous. It is composed of a diverse array of immune cells that are recruited continuously into lesions. They are guided into the tumor through interactions between chemokines and their receptors. A variety of chemokine receptors are expressed on the surface of both tumor and immune cells rendering them sensitive to multiple stimuli that can subsequently influence their migration and function. These features significantly impact tumor fate and are critical in melanoma control and progression. Indeed, particular chemokine receptors expressed on tumor and immune cells are strongly associated with patient prognosis. Thus, potential targeting of chemokine receptors is highly attractive as ameans to quench or eliminate unconstrained tumor cell growth.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available